Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103641462 | 10364146 | 2 | F | 20160627 | 20140806 | 20160705 | EXP | CA-AMGEN-CANSP2014057750 | AMGEN | STEPHEN B. SINGH, INGRID A. HARLE.. TAKOTSUBO CARDIOMYOPATHY SECONDARY IN PART TO CANCER-RELATED PAIN CRISIS: A CASE REPORT. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2014;48:137 - 142 | 59.00 | YR | A | F | Y | 0.00000 | 20160705 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103641462 | 10364146 | 1 | PS | XGEVA | DENOSUMAB | 1 | Unknown | UNK | U | 125320 | SOLUTION FOR INJECTION | ||||||||
103641462 | 10364146 | 2 | SS | PROLIA | DENOSUMAB | 1 | Subcutaneous | UNK | U | 0 | SOLUTION FOR INJECTION | ||||||||
103641462 | 10364146 | 3 | SS | FENTANYL. | FENTANYL | 1 | Intravenous (not otherwise specified) | 35 MUG, AS NECESSARY | 0 | 35 | UG | ||||||||
103641462 | 10364146 | 4 | SS | GEFITINIB | GEFITINIB | 1 | Unknown | UNK | 0 | ||||||||||
103641462 | 10364146 | 5 | SS | HYDROMORPHONE | HYDROMORPHONE | 1 | Oral | 15 MG, Q12H | 0 | 15 | MG | BID | |||||||
103641462 | 10364146 | 6 | SS | HYDROMORPHONE | HYDROMORPHONE | 1 | Oral | 4 MG, Q2H | 0 | 4 | MG | ||||||||
103641462 | 10364146 | 7 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
103641462 | 10364146 | 8 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | 0 | |||||||||||
103641462 | 10364146 | 9 | C | NORTRIPTYLINE | NORTRIPTYLINE | 1 | Oral | UNK | 0 | ||||||||||
103641462 | 10364146 | 10 | C | ONDANSETRON | ONDANSETRON | 1 | UNK | 0 | |||||||||||
103641462 | 10364146 | 11 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
103641462 | 10364146 | 12 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | UNK | 0 | |||||||||||
103641462 | 10364146 | 13 | C | DALTEPARIN SODIUM | DALTEPARIN SODIUM | 1 | Subcutaneous | UNK | 0 | ||||||||||
103641462 | 10364146 | 14 | C | DALTEPARIN SODIUM | DALTEPARIN SODIUM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
103641462 | 10364146 | 1 | Product used for unknown indication |
103641462 | 10364146 | 2 | Product used for unknown indication |
103641462 | 10364146 | 3 | Product used for unknown indication |
103641462 | 10364146 | 4 | Product used for unknown indication |
103641462 | 10364146 | 5 | Pain |
103641462 | 10364146 | 7 | Blood pressure increased |
103641462 | 10364146 | 13 | Renal vein thrombosis |
103641462 | 10364146 | 14 | Vena cava thrombosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
103641462 | 10364146 | OT |
103641462 | 10364146 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
103641462 | 10364146 | Acute myocardial infarction | |
103641462 | 10364146 | Areflexia | |
103641462 | 10364146 | Arthralgia | |
103641462 | 10364146 | Back pain | |
103641462 | 10364146 | Blood pressure increased | |
103641462 | 10364146 | Cardiac failure congestive | |
103641462 | 10364146 | Chest pain | |
103641462 | 10364146 | Confusional state | |
103641462 | 10364146 | Dyspnoea | |
103641462 | 10364146 | Muscular weakness | |
103641462 | 10364146 | Myoclonus | |
103641462 | 10364146 | Spinal cord compression | |
103641462 | 10364146 | Stress cardiomyopathy | |
103641462 | 10364146 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |